Q4 2023 · 13F-HR
Samsara BioCapital, LLCholdings as filed
Filed 2024-02-14 · accession 0001104659-24-023801
$642.8M
Reported value
41
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $127.6M | 19.9% | 6,788,609 | Common | SOLE |
| 75525N107 | — | RAYZEBIO INC | $114.8M | 17.9% | 1,845,948 | Common | SOLE |
| 14179K101 | CRGX | CARGO THERAPEUTICS INC | $95.4M | 14.8% | 4,121,689 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $38.9M | 6.05% | 4,519,361 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $25.6M | 3.98% | 460,441 | Common | SOLE |
| 64135M105 | NGNE | NEUROGENE INC | $24.6M | 3.82% | 1,267,790 | Common | SOLE |
| 38870X104 | GRPH | GRAPHITE BIO INC | $22.2M | 3.45% | 8,459,314 | Common | SOLE |
| 65487U108 | NKTX | NKARTA INC | $18.9M | 2.94% | 2,868,035 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $18.8M | 2.93% | 2,523,022 | Common | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $15.2M | 2.36% | 1,458,875 | Common | SOLE |
| 55234L105 | LYRAGBP | LYRA THERAPEUTICS INC | $14.6M | 2.27% | 2,780,261 | Common | SOLE |
| 87184Q206 | SYRS | SYROS PHARMACEUTICALS INC | $13.9M | 2.16% | 1,786,427 | Common | SOLE |
| 05337M104 | — | AVADEL PHARMACEUTICALS PLC | $13.7M | 2.13% | 967,527 | Common | SOLE |
| 43157M102 | — | HILLEVAX INC | $12.8M | 2.00% | 799,274 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $9.1M | 1.41% | 850,000 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $7.9M | 1.23% | 172,647 | Common | SOLE |
| 869367102 | — | SUTRO BIOPHARMA INC | $7.2M | 1.12% | 1,675,579 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $6.9M | 1.07% | 347,500 | Common | SOLE |
| 449778109 | IOBTQ | IO BIOTECH INC | $6.8M | 1.06% | 3,640,015 | Common | SOLE |
| 45790W108 | — | INOZYME PHARMA INC | $6.7M | 1.04% | 1,562,500 | Common | SOLE |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $6.2M | 0.97% | 630,000 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $5.6M | 0.87% | 6,130,268 | Common | SOLE |
| N44445109 | IMTX | IMMATICS N.V | $4.2M | 0.65% | 396,000 | Common | SOLE |
| 74168J101 | PRME | PRIME MEDICINE INC | $4.2M | 0.65% | 470,304 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $3.9M | 0.60% | 360,414 | Common | SOLE |
| 713317105 | PEPG | PEPGEN INC | $3.0M | 0.46% | 436,813 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $2.9M | 0.45% | 196,425 | Common | SOLE |
| 52187K200 | CYPH | LEAP THERAPEUTICS INC | $2.8M | 0.43% | 669,303 | Common | SOLE |
| 75082Q105 | — | RAIN ONCOLOGY INC | $2.4M | 0.38% | 2,034,552 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $1.3M | 0.20% | 202,348 | Common | SOLE |
| 449585108 | 1K0 | IGM BIOSCIENCES INC | $1.3M | 0.20% | 154,664 | Common | SOLE |
| 097702104 | BOLT1EUR | BOLT BIOTHERAPEUTICS INC | $1.2M | 0.18% | 1,049,153 | Common | SOLE |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $730,980 | 0.11% | 696,171 | Common | SOLE |
| 918385204 | VTVT | VTV THERAPEUTICS INC | $470,212 | 0.07% | 40,888 | Common | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $469,803 | 0.07% | 172,089 | Common | SOLE |
| 92765F108 | RYI | VIRACTA THERAPEUTICS INC | $393,134 | 0.06% | 689,709 | Common | SOLE |
| 808644207 | 6QV | SCIENCE 37 HOLDINGS INC | $240,300 | 0.04% | 45,000 | Common | SOLE |
| 50107A104 | KRON1USD | KRONOS BIO INC | $97,664 | 0.02% | 78,131 | Common | SOLE |
| 019818103 | — | ALLOVIR INC | $55,972 | 0.01% | 82,336 | Common | SOLE |
| 67080N119 | NUVB/WS | NUVATION BIO INC | $8,000 | 0.00% | 133,333 | Common | SOLE |
| 86889P117 | SRZNW | SURROZEN INC | $1,940 | 0.00% | 99,999 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.